Home » Newsletters » BioWorld Science

BioWorld Science

June 12, 2014

View Archived Issues

Sentitive LSPR-based biosensor rapidly detects cancer biomarkers in serum

Genetically engineered epothilone analogue shows promising efficacy in metastatic breast cancer

CLOCK gene polymorphisms found to be associated with recurrent spontaneous abortions

Mutations in the YY1 gene are linked to intellectual disability

AstraZeneca and Cancer Genetics collaborate on cancer in Central America and the Caribbean

Seres Health closes financing and establishes research collaboration with Mayo Clinic

RPC-1063 meets primary endpoint in phase II study

Inovio's INO-3112 enters phase I/IIa trial in head and neck cancer

Batu Biologics outlines development plans for ValloVax

British investigators describe novel kinase inhibitors for inflammatory diseases

Boehringer Ingelheim's afatinib obtains FDA orphan drug status

Mei Pharma reports data from phase II study of pracinostat in AML

Feasible imaging of joint inflammation with novel radiolabeled anti-FAP antibody

Rosetta Genomics to work with Moffitt Cancer Center on thyroid neoplasia assay

U.S. investigators disclose novel compounds for lysosomal storage diseases

New patent describes novel agents for bacterial and fungal infections

Array BioPharma patents detail novel Trk-A inhibitors

Tonix Pharmaceuticals receives IND clearance for TNX-102 in PTSD

NovaDigm Therapeutics acquires rights to three Candida vaccine antigens

European orphan drug designation awarded to Betalutin for follicular lymphoma

Researchers report data on MAb targeting glypican-3 for HCC

FDA extends review date of NB-32 NDA

Data and safety monitoring board recommends continuation of phase III study of CPX-351

Celsion to acquire EGEN in June 2014

Allergan rejects revised Valeant proposal

Takelda launched in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...